Castle Biosciences, Inc.CSTLNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.0%
5Y CAGR+36.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+17.0%/yr
vs +71.7%/yr prior
5Y CAGR
+36.6%/yr
Recent deceleration
Acceleration
-54.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $229.32M | +14.6% |
| 2024 | $200.05M | +11.0% |
| 2023 | $180.15M | +26.0% |
| 2022 | $143.00M | +64.9% |
| 2021 | $86.74M | +80.2% |
| 2020 | $48.13M | +61.3% |
| 2019 | $29.84M | +81.2% |
| 2018 | $16.47M | +7.9% |
| 2017 | $15.26M | - |